Moderated Discussion – Assessing the Current & Future Landscapes for Preclinical Models

Time: 12:50 pm
day: Day One


  • Dissecting the advantages and disadvantages of current established preclinical models
  • Ascertaining what should be done to improve translatability of animal models without extending drug development timeline
  • Expanding our understanding of mechanisms driving safety for HFpEF targeted candidates